Press release
Seasonal Allergic Rhinitis Treatment Market Size in the 7MM is expected to experience steady growth by 2032, estimates DelveInsight | Regeneron Pharmaceuticals, Revolo Biotherapeutics, Allergy Therapeutics, Emergo Therapeutics
Seasonal Allergic Rhinitis Market
Discover Key Insights into the Seasonal Allergic Rhinitis Market with DelveInsight's In-Depth Report @ Seasonal Allergic Rhinitis Market Size- https://www.delveinsight.com/sample-request/seasonal-allergic-rhinitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Seasonal Allergic Rhinitis Market Report
• Out of the 7MM, EU4 and the UK accounted for 43% of the total diagnosed prevalent cases of Seasonal Allergic Rhinitis in 2022.
• Age-specific diagnosed prevalent cases of Seasonal Allergic Rhinitis in the following age groups, i.e., 0-10 years, 10-17 years, 18-59 years, and 60+ years, respectively.
• In 2022, the highest diagnosed prevalent cases of Seasonal Allergic Rhinitis among EU4 and the UK were observed in Germany, whereas Spain reported the minimum number of cases.
• Allergen-specific sensitivity is further distributed into various allergen groups, which include grass pollen, mites, tree pollen, animal dander, fungal spores, and weed pollen, to understand the frequently detected allergens in the Seasonal Allergic Rhinitis patient pool.
• The leading Seasonal Allergic Rhinitis Companies such as Regeneron Pharmaceuticals, Revolo Biotherapeutics, Allergy Therapeutics, Emergo Therapeutics, etc., and others.
• Promising Seasonal Allergic Rhinitis Therapies such as RYALTRIS, XOLAIR (omalizumab), RAGWITEK/ RAGWIZAX, and others.
Stay ahead in the Seasonal Allergic Rhinitis Therapeutics Market with DelveInsight's Strategic Report @ Seasonal Allergic Rhinitis Market Outlook- https://www.delveinsight.com/sample-request/seasonal-allergic-rhinitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Seasonal Allergic Rhinitis Epidemiology Segmentation in the 7MM
• Seasonal Allergic Rhinitis Diagnosed Prevalent Cases
• Seasonal Allergic Rhinitis Age-specific Diagnosed Prevalent Cases
• Seasonal Allergic Rhinitis Severity-specific Diagnosed Prevalent Cases
• Allergen-specific Diagnosed Prevalent Cases
Download the report to understand which factors are driving Seasonal Allergic Rhinitis epidemiology trends @ Seasonal Allergic Rhinitis Prevalence- https://www.delveinsight.com/sample-request/seasonal-allergic-rhinitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Seasonal Allergic Rhinitis Market Outlook
The current Seasonal Allergic Rhinitis Drugs Market has medications, including antihistamines, nasal sprays, and immunotherapies, whereas the emerging market shows novel treatments offering better symptom relief and targeted approaches. Drug therapy includes oral antihistamines to suppress runny noses through the inhibition of histamine action in the body, nasal steroids to suppress nasal inflammation, decongestants, and anticholinergic medications to provide temporary relief from nasal congestion, and leukotriene receptor antagonists to improve nasal congestion. In addition, mast cell stabilizers prevent the release of histamine and other inflammatory substances.
Seasonal Allergic Rhinitis Marketed Drugs
• RYALTRIS (olopatadine hydrochloride and mometasone furoate monohydrate): Glenmark Pharmaceuticals Inc.
RYALTRIS, a fixed-dose combination nasal spray containing an antihistamine and a steroid, was granted approval by the US FDA in January 2022 for treating symptoms related to seasonal allergic rhinitis in adults and pediatric patients aged 12 and above. Before this, in August 2021, Glenmark Pharmaceuticals obtained marketing approval for Ryaltris, its fixed-dose combination nasal spray, in 13 countries within the European Union and the United Kingdom.
• XOLAIR (omalizumab): Novartis Pharmaceuticals
In December 2019, Novartis received approval for the additional XOLAIR (Omalizumab) indication for seasonal allergic rhinitis in Japan to treat severe Japanese cedar pollinosis. XOLAIR is a humanized monoclonal anti-IgE antibody administered subcutaneously and plays a vital role in developing allergic inflammation.
• RAGWITEK/ RAGWIZAX: ALK-Abello
In April 2021, ALK-Abello obtained approval from the US FDA for RAGWITEK, a sublingual tablet containing short ragweed pollen allergen extract, for the treatment of allergic rhinitis caused by short ragweed pollen in individuals ranging from 5 to 65 years of age. Previously, in October 2020, it was approved under the brand name RAGWIZAX in European children.
Get In-Depth Knowledge on Seasonal Allergic Rhinitis Market Trends and Forecasts with DelveInsight @ Seasonal Allergic Rhinitis Treatment Market-= https://www.delveinsight.com/sample-request/seasonal-allergic-rhinitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Emerging Seasonal Allergic Rhinitis Drugs
• REGN5713-5714-5715: Regeneron Pharmaceuticals
REGN5713-5714-5715 is currently developing as a treatment for seasonal allergic rhinitis caused by birch pollen allergy. This therapeutic candidate is a combination of three human monoclonal antibodies and works by specifically targeting the pollen allergen Bet v 1. It can be administered via IV or SC routes.
• IRL201104: Revolo Biotherapeutics
IRL-201104 is under development for several indications, including seasonal allergic rhinitis. The drug candidate is a peptide derived from chaperonin 60.1 of Mycobacterium tuberculosis. It can be administered via IV or SC routes. The company has recently completed its trials in Phase II.
Scope of the Seasonal Allergic Rhinitis Market Report
• Coverage- 7MM
• Seasonal Allergic Rhinitis Companies- Regeneron Pharmaceuticals, Revolo Biotherapeutics, Allergy Therapeutics, Emergo Therapeutics, etc., and others.
• Seasonal Allergic Rhinitis Therapies- RYALTRIS, XOLAIR (omalizumab), RAGWITEK/ RAGWIZAX, and others.
• Seasonal Allergic Rhinitis Therapeutic Assessment: Seasonal Allergic Rhinitis current marketed and Seasonal Allergic Rhinitis emerging therapies
• Seasonal Allergic Rhinitis Market Dynamics: Seasonal Allergic Rhinitis market drivers and Seasonal Allergic Rhinitis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Seasonal Allergic Rhinitis Unmet Needs, KOL's views, Analyst's views, Seasonal Allergic Rhinitis Market Access and Reimbursement
Unlock Strategic Insights with DelveInsight's Comprehensive Seasonal Allergic Rhinitis Market Report @ Seasonal Allergic Rhinitis Market Drivers and Barriers- https://www.delveinsight.com/sample-request/seasonal-allergic-rhinitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1 Key Insights
2 Report Introduction
3 Seasonal Allergic Rhinitis Market Overview at a Glance
4 Executive Summary of Seasonal Allergic Rhinitis
5 Key Events
6 Disease Background and Overview: Seasonal Allergic Rhinitis
7 Epidemiology and Patient Population
8 Patient Journey
9 Marketed Drugs
10 Emerging Therapies
11 Seasonal Allergic Rhinitis: Seven Major Market Analysis
12 Key Opinion Leaders' Views
13 Unmet Needs
14 SWOT Analysis
15 Market Access and Reimbursement
16 Appendix
17 DelveInsight Capabilities
18 Disclaimer
19 About DelveInsight
List of Top Selling Market Research Reports in 2025
Intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Urea cycle disorders market- https://www.delveinsight.com/blog/urea-cycle-disorder-market
Phototherapies for psoriasis market- https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
Vascular access devices market- https://www.delveinsight.com/report-store/vascular-access-device-market
NK cell therapy market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Cardiac monitoring devices market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Lactose intolerance market- https://www.delveinsight.com/report-store/lactose-intolerance-market
Ventral hernia market- ttps://www.delveinsight.com/report-store/hernia-repair-devices-market
Medical marijuana market- https://www.delveinsight.com/report-store/medical-marijuana-market
Total knee arthroplasty market- https://www.delveinsight.com/report-store/knee-reconstruction-devices-market
Surgical energy instruments market- https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
Surgical sealant market- https://www.delveinsight.com/report-store/surgical-sealant-and-adhesives-market
Baricose vein treatment devices market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Pouchitis market- https://www.delveinsight.com/report-store/pouchitis-market
Diabetic wound market- https://www.delveinsight.com/report-store/diabetic-wounds-market
Healthcare competitive benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
Transcatheter treatment market- https://www.delveinsight.com/report-store/transcatheter-treatment-market
Indwelling catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Overactive bladder syndrome market- https://www.delveinsight.com/report-store/overactive-bladder-oab-market
Chronic neuropathic pain market- https://www.delveinsight.com/report-store/chronic-neuropathic-pain-market
Microscopy device market- https://www.delveinsight.com/report-store/microscopy-device-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Seasonal Allergic Rhinitis Treatment Market Size in the 7MM is expected to experience steady growth by 2032, estimates DelveInsight | Regeneron Pharmaceuticals, Revolo Biotherapeutics, Allergy Therapeutics, Emergo Therapeutics here
News-ID: 3889436 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Seasonal
5 Seasonal Realism Hoodie Trends Popular Now
Relaxed tailoring is everywhere this season. Blazers hang loose with softer lines. Pants flow easy without sharp creases. Comfort meets structure in perfect balance. Oversized suits rule both work events. Wide-legged trousers make a smooth return. Boxy jackets layer over fine shirts. It's elegance made effortless and modern. Traditional cuts get a fresh edit. Tailored pieces now feel light and airy. Structured shoulders soften with natural movement. Casual realism hoodie…
Maximizing HVAC Efficiency During Seasonal Transitions
Seasonal transitions can be a bit of a rollercoaster, right? One day it's chilly enough to need a blanket, the next it's warm enough to consider cranking up the AC. Your HVAC system gets a serious workout during these times, and if it's not prepared, you could be left with uneven temperatures, high energy bills, or worse-an unexpected breakdown.
But don't worry, we've got your back. With just a few simple…
Protecting Hicksville Homes from Seasonal Pest Infestations
Seasonal changes often bring a surge in pest activity, making it crucial for homeowners in Hicksville to stay vigilant. Different pests become more active depending on the time of year, posing risks to both the comfort and safety of homes. At Majestic Pest Control - Hicksville Exterminator Service, we understand the challenges these infestations present and offer tailored solutions to protect local properties effectively.
Here's an in-depth look at the types…
Tips to Triumph over Seasonal Allergies
Allergy season has arrived and brought with it a haze of pollen and allergens, leaving millions of affected individuals longing for relief. The health experts at Envolve, an integrated healthcare solutions company, have put together a few tips to help you proactively manage your exposure and response to allergens and allergy triggers – and help you get through allergy season more comfortably.
Consider allergy testing. Consult your primary care provider (PCP)…
Nordics Countries Seasonal Influenza Vaccine Market
Nordics Seasonal Influenza Vaccine Market Forecast in (Denmark, Finland, Iceland, Norway & Sweden) By (Child & Adult) Vaccination report published by Renub Research. According to this report, Sweden is having the highest seasonal influenza vaccine market share. In terms of children vaccination, Sweden & Denmark hold nearly 70 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than 60 percent market share by 2022.
This…
Seasonal Influenza Vaccination Market in Baltic Countries
Seasonal Influenza Vaccination Market in Lithuania, Estonia, Latvia (Baltic Countries) By (Child & Adult) Forecast report published by Renub Research. According to this report, in the Baltic Countries, Lithuania is having the highest seasonal influenza vaccine market share followed by Latvia and Estonia. In terms of children vaccination, Lithuania & Latvia hold nearly 70 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than…
